🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

LAURA Trial receives a well deserved huge applause by the audience. Huge benefit in PFS (39 vs 5.6 mo, HR < 0.2. OS still immature and 81% crossover. STAGE III EGFR+ NSCLC INCURABLE? BRAIN RMN BUT NO PET-CT required at baseline. #ASCO24 Lecia Sequist, MD, MPH

And now... updated results of 41 patients CURATIVELY treated with 6m of Dostarlimab (PD-1) WITHOUT ☢️or🔪 ✅100% cCR rate ✅0 Local or distance relapses ✅Sustained cCR for > 12 m seen in 20 patients with mFU of 29 m THIS. IS. AWESOME #ASCO24

We are hiring!! We are looking for two associate editors for Clinical & Translational Radiation Oncology! Apply now if you want to be part of a rapidly growing radiotherapy journal by ESTRO! ctro.science/content/callfo… #radonc

🦴 Study on Osteolytic Metastases (SM) Remineralization 🔬 Conclusion: Radiation therapy significantly increases BMD in lytic SM (except renal tumors). No additional benefit of SBRT over cEBRT. Important for surgical decisions in unstable patients. ctro.science/article/S2405-…

Should preoperative SRS be considered for brain metastases undergoing resection? Great to work with Neda Haghighi arjun sahgal Hany on our Clinical & Translational Radiation Oncology editorial of the PREOP-1 trial. More prospective evidence for this novel paradigm! Sunnybrook Health Sciences Centre Radiation Oncology Peter Mac Radiation Oncology

🔹LDR Brachytherapy for recurrent prostate cancer after definitive radiotherapy ctro.science/article/S2405-… #radonc

A day in the life of an editor in chief... @ctro_journal #radonc

Compliance to MDT recs in OMD pts: 👉83.7% of MDT recommendations correctly implemented 👉Reasons for major deviations: physician decision, patient comorbidity or patient decision. 👉Major deviations associated with more than one distant met and worse OS doi.org/10.1016/j.ctro…

ctro.science/article/S2405-…

ctro.science/article/S2405-…

ctro.science/article/S2405-…

ctro.science/article/S2405-…

ctro.science/article/S2405-…

👉 94 patients with isolated local relapse of prostate cancer after definitive irradiation. 👉 Salvage I-125 low-dose-rate brachytherapy was performed in a Comprehensive Cancer Center. 👉 Treatment of whole gland (70%) +- with an MRI-based GTV boost (20%) or focal (10%).